ardorcomm

Health news 22nd July 2022 ardorcomm NTAGI panel reviews data for Corbevax as booster for adults who got Covishield, Covaxin shots

NTAGI panel reviews data for Corbevax as booster for adults who got Covishield, Covaxin shots

According to official sources, the National Technical Advisory Group on Immunization’s Covid working group has examined the data of Biological E’s Corbevax to allow it as a booster for those aged 18 and over completely vaccinated with Covishield or Covaxin.

The NTAGI panel did not yet make a recommendation at their meeting on Wednesday. On June 4, the Drugs Controller General of India (DCGI) approved Corbevax as a precautionary dose for individuals 18 years of age and above.

Corbevax, India’s first locally produced RBD protein subunit vaccine, is currently being administered to children between the ages of 12 and 14. According to an official source who spoke to the media agency, “The NTAGI panel reviewed the data of Biological E’s Corbevax as a booster for those aged 18 and above fully vaccinated with either Covishield or Covaxin,”

In accordance with a 75-day special drive that started on July 15, everyone aged 18 and over is receiving free precautionary doses of the Covid vaccine at government immunisation centres. As part of the government’s Azadi Ka Amrit Mahotsav to commemorate the 75th anniversary of India’s Independence, the “COVID Vaccination Amrit Mahotsava” programme is being undertaken with the intention of increasing the adoption of Covid precaution dosages. To date, the nation has administered more than 6 crore precautionary doses.

Leave a Comment

Your email address will not be published.